Andre J. McDonald, Amanda Doggett, Kyla Belisario, Jessica Gillard, Jane De Jesus, Emily Vandehei, Laura Lee, Jillian Halladay, James MacKillop
{"title":"加拿大娱乐性大麻合法化后 5 年内大麻使用和滥用的纵向变化:社区成年人前瞻性队列研究","authors":"Andre J. McDonald, Amanda Doggett, Kyla Belisario, Jessica Gillard, Jane De Jesus, Emily Vandehei, Laura Lee, Jillian Halladay, James MacKillop","doi":"10.1101/2024.08.06.24311571","DOIUrl":null,"url":null,"abstract":"Importance: A growing number of jurisdictions have legalized recreational cannabis for adults, but most evaluations have used repeated cross-sectional designs, preventing examination of within-person and subgroup trajectories across legalization. Objective: To examine changes in cannabis use and misuse in the five years following legalization in Canada - the first G7 country to legalize adult recreational cannabis use - both overall and by pre-legalization cannabis use frequency using a longitudinal design. Design: Prospective cohort study with 11 biannual assessments from September 2018 to October 2023. Mean retention was 90% across all waves. Setting: Ontario, Canada. Participants: Sample of 1,428 (60.2% female, Mage=34.5) community adults aged 18 to 65 years. Exposure: Five years of recreational cannabis legalization (the baseline wave was immediately prior to legalization). Main outcome and measures: Primary outcomes were cannabis use frequency and cannabis misuse (CUDIT-R score). Pre-legalization cannabis use frequency, age, and sex were examined as moderators. Secondary outcomes included changes in cannabis product preferences over time. Results: Linear mixed effects modelling found a significant increase in cannabis use frequency, such that the mean proportion of days using cannabis increased by 0.35% (p<.001) per year in the overall sample (1.75% over 5 years). In contrast, CUDIT-R scores (on scale of 0 to 32) decreased significantly overall (b=-0.08 [-0.4 over 5 years], p<.001), most notably following the onset of the COVID-19 pandemic. Interaction analyses indicated that pre-legalization cannabis use frequency significantly moderated changes for both outcomes (p<.001). Specifically, cannabis use and misuse decreased among pre-legalization frequent consumers and modestly increased among occasional/non-users. Cannabis product preferences shifted away from dried flower, hashish, concentrates, oil, tinctures, and topicals to edibles, liquids, and vape pens. Conclusions and Relevance: In the five years following legalization, cannabis use frequency increased modestly, while cannabis misuse decreased modestly in a longitudinal observational cohort of Canadian adults. These changes were substantially moderated by pre-legalization cannabis use, with more frequent consumers of cannabis pre-legalization exhibiting the largest decreases in both outcomes. Although longer-term surveillance is required, these results suggest Canadian recreational cannabis legalization was associated with modest negative consequences and some evidence of positive outcomes among nonclinical community adults.","PeriodicalId":501276,"journal":{"name":"medRxiv - Public and Global Health","volume":"6 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Longitudinal changes in cannabis use and misuse in the 5 years following recreational cannabis legalization in Canada: A prospective cohort study of community adults\",\"authors\":\"Andre J. McDonald, Amanda Doggett, Kyla Belisario, Jessica Gillard, Jane De Jesus, Emily Vandehei, Laura Lee, Jillian Halladay, James MacKillop\",\"doi\":\"10.1101/2024.08.06.24311571\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Importance: A growing number of jurisdictions have legalized recreational cannabis for adults, but most evaluations have used repeated cross-sectional designs, preventing examination of within-person and subgroup trajectories across legalization. Objective: To examine changes in cannabis use and misuse in the five years following legalization in Canada - the first G7 country to legalize adult recreational cannabis use - both overall and by pre-legalization cannabis use frequency using a longitudinal design. Design: Prospective cohort study with 11 biannual assessments from September 2018 to October 2023. Mean retention was 90% across all waves. Setting: Ontario, Canada. Participants: Sample of 1,428 (60.2% female, Mage=34.5) community adults aged 18 to 65 years. Exposure: Five years of recreational cannabis legalization (the baseline wave was immediately prior to legalization). Main outcome and measures: Primary outcomes were cannabis use frequency and cannabis misuse (CUDIT-R score). Pre-legalization cannabis use frequency, age, and sex were examined as moderators. Secondary outcomes included changes in cannabis product preferences over time. Results: Linear mixed effects modelling found a significant increase in cannabis use frequency, such that the mean proportion of days using cannabis increased by 0.35% (p<.001) per year in the overall sample (1.75% over 5 years). In contrast, CUDIT-R scores (on scale of 0 to 32) decreased significantly overall (b=-0.08 [-0.4 over 5 years], p<.001), most notably following the onset of the COVID-19 pandemic. Interaction analyses indicated that pre-legalization cannabis use frequency significantly moderated changes for both outcomes (p<.001). Specifically, cannabis use and misuse decreased among pre-legalization frequent consumers and modestly increased among occasional/non-users. Cannabis product preferences shifted away from dried flower, hashish, concentrates, oil, tinctures, and topicals to edibles, liquids, and vape pens. Conclusions and Relevance: In the five years following legalization, cannabis use frequency increased modestly, while cannabis misuse decreased modestly in a longitudinal observational cohort of Canadian adults. These changes were substantially moderated by pre-legalization cannabis use, with more frequent consumers of cannabis pre-legalization exhibiting the largest decreases in both outcomes. Although longer-term surveillance is required, these results suggest Canadian recreational cannabis legalization was associated with modest negative consequences and some evidence of positive outcomes among nonclinical community adults.\",\"PeriodicalId\":501276,\"journal\":{\"name\":\"medRxiv - Public and Global Health\",\"volume\":\"6 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-08-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"medRxiv - Public and Global Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1101/2024.08.06.24311571\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Public and Global Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.08.06.24311571","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Longitudinal changes in cannabis use and misuse in the 5 years following recreational cannabis legalization in Canada: A prospective cohort study of community adults
Importance: A growing number of jurisdictions have legalized recreational cannabis for adults, but most evaluations have used repeated cross-sectional designs, preventing examination of within-person and subgroup trajectories across legalization. Objective: To examine changes in cannabis use and misuse in the five years following legalization in Canada - the first G7 country to legalize adult recreational cannabis use - both overall and by pre-legalization cannabis use frequency using a longitudinal design. Design: Prospective cohort study with 11 biannual assessments from September 2018 to October 2023. Mean retention was 90% across all waves. Setting: Ontario, Canada. Participants: Sample of 1,428 (60.2% female, Mage=34.5) community adults aged 18 to 65 years. Exposure: Five years of recreational cannabis legalization (the baseline wave was immediately prior to legalization). Main outcome and measures: Primary outcomes were cannabis use frequency and cannabis misuse (CUDIT-R score). Pre-legalization cannabis use frequency, age, and sex were examined as moderators. Secondary outcomes included changes in cannabis product preferences over time. Results: Linear mixed effects modelling found a significant increase in cannabis use frequency, such that the mean proportion of days using cannabis increased by 0.35% (p<.001) per year in the overall sample (1.75% over 5 years). In contrast, CUDIT-R scores (on scale of 0 to 32) decreased significantly overall (b=-0.08 [-0.4 over 5 years], p<.001), most notably following the onset of the COVID-19 pandemic. Interaction analyses indicated that pre-legalization cannabis use frequency significantly moderated changes for both outcomes (p<.001). Specifically, cannabis use and misuse decreased among pre-legalization frequent consumers and modestly increased among occasional/non-users. Cannabis product preferences shifted away from dried flower, hashish, concentrates, oil, tinctures, and topicals to edibles, liquids, and vape pens. Conclusions and Relevance: In the five years following legalization, cannabis use frequency increased modestly, while cannabis misuse decreased modestly in a longitudinal observational cohort of Canadian adults. These changes were substantially moderated by pre-legalization cannabis use, with more frequent consumers of cannabis pre-legalization exhibiting the largest decreases in both outcomes. Although longer-term surveillance is required, these results suggest Canadian recreational cannabis legalization was associated with modest negative consequences and some evidence of positive outcomes among nonclinical community adults.